Commentary: Safety and efficacy of remimazolam versus propofol sedation in gynecological procedures: a meta-analysis of East Asian randomized trials - Takeaways - MDSpire

Commentary: Safety and efficacy of remimazolam versus propofol sedation in gynecological procedures: a meta-analysis of East Asian randomized trials

  • By

  • Munder Lateiresh

  • June 16, 2026

  • 0 min

Share

  • 1

    Remimazolam shows a superior safety profile compared to propofol, with lower rates of adverse events, respiratory depression, and hypotension.

  • 2

    Methodological issues in the meta-analysis include discrepancies in data extraction and outcome definitions, particularly regarding hypotension.

  • 3

    The classification of intervention arms in the meta-analysis may introduce clinical heterogeneity, especially with combination regimens.

  • 4

    The handling of multi-arm trials in the meta-analysis requires careful methodological consideration to avoid bias in pooled estimates.

  • 5

    A thorough evaluation of evidence certainty is necessary to assess the robustness of findings in the meta-analysis of remimazolam and propofol.

Original Source(s)

Commentary: Safety and efficacy of remimazolam versus propofol sedation in gynecological procedures: a meta-analysis of East Asian randomized trials

  • by Munder Lateiresh

  • June 16, 2026

Related Content

Postoperative breast function and quality of life follow-up study in patients with plasma cell mastitis: a 1-year longitudinal analysis

Comparison of efficacy and safety between native tissue repair and transvaginal mesh for uterine prolapse: a retrospective study

The predictive value of fresh embryo transfer pregnancy results on frozen embryo transfer outcomes: a cohort study